FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2152068912> ?p ?o ?g. }

• W2152068912 endingPage "318.e4" @default.
• W2152068912 startingPage "312" @default.
• W2152068912 abstract "Purpose To characterize the clinical features of Behçet’s disease in Chinese patients. Design Retrospective noncomparative case series. Participants Seven hundred seventy-five eyes of 437 patients with Behçet’s disease initially examined from August, 1995, through June, 2006. Methods The history, demographic parameters, and clinical findings of all consecutive Behçet’s patients referred to the uveitis study center of Sun Yat-sen University were reviewed. Laser flare-cell photometry (LFCM), fundus fluorescein angiography (FFA), optical coherence tomography (OCT), ultrasound biomicroscopy (UBM), and B-scan ultrasonography were performed in certain cases. Most patients were treated by immunosuppressive agents combined with oral corticosteroids. Main Outcome Measures Patient demographics, clinical presentation, and auxiliary examination findings. Results Four hundred thirty-seven patients were diagnosed with Behçet’s disease. There were 319 male and 118 female patients. Panuveitis was the most common type of uveitis in both genders, although anterior uveitis was seen more frequently in females. Retinal vasculitis, vitreitis, and retinitis were the most common ocular manifestations in these patients. Cataract and macular edema were the most common complications. Oral aphthae were the most frequent extraocular manifestation, followed by dermatologic lesions, and genital ulcers. The results of FFA, OCT, B-scan ultrasonography, LFCM, and UBM generally were in accordance with or comparable with clinical observations. At the final visit, uveitis was well controlled in 86.2% of patients. However, 20.4% of eyes became legally blind despite aggressive treatment. Kaplan-Meier analysis estimated the risk of losing useful vision (0.05) at 5 and 10 years for males and females as 29% versus 6% and 65% versus 33%, respectively. Conclusions Behçet’s disease in Chinese patients mainly manifests as nongranulomatous uveitis frequently associated with oral aphthae and dermatologic lesions. Fundus fluorescein angiography, B-scan ultrasonography, LFCM, UBM, and OCT may provide much information about pathophysiologic hallmarks of Behçet’s disease. A combination of corticosteroids with other immunosuppressive agents is effective for most patients with Behçet’s disease. Males had a more severe course and were at higher risk for losing vision than females. To characterize the clinical features of Behçet’s disease in Chinese patients. Retrospective noncomparative case series. Seven hundred seventy-five eyes of 437 patients with Behçet’s disease initially examined from August, 1995, through June, 2006. The history, demographic parameters, and clinical findings of all consecutive Behçet’s patients referred to the uveitis study center of Sun Yat-sen University were reviewed. Laser flare-cell photometry (LFCM), fundus fluorescein angiography (FFA), optical coherence tomography (OCT), ultrasound biomicroscopy (UBM), and B-scan ultrasonography were performed in certain cases. Most patients were treated by immunosuppressive agents combined with oral corticosteroids. Patient demographics, clinical presentation, and auxiliary examination findings. Four hundred thirty-seven patients were diagnosed with Behçet’s disease. There were 319 male and 118 female patients. Panuveitis was the most common type of uveitis in both genders, although anterior uveitis was seen more frequently in females. Retinal vasculitis, vitreitis, and retinitis were the most common ocular manifestations in these patients. Cataract and macular edema were the most common complications. Oral aphthae were the most frequent extraocular manifestation, followed by dermatologic lesions, and genital ulcers. The results of FFA, OCT, B-scan ultrasonography, LFCM, and UBM generally were in accordance with or comparable with clinical observations. At the final visit, uveitis was well controlled in 86.2% of patients. However, 20.4% of eyes became legally blind despite aggressive treatment. Kaplan-Meier analysis estimated the risk of losing useful vision (0.05) at 5 and 10 years for males and females as 29% versus 6% and 65% versus 33%, respectively. Behçet’s disease in Chinese patients mainly manifests as nongranulomatous uveitis frequently associated with oral aphthae and dermatologic lesions. Fundus fluorescein angiography, B-scan ultrasonography, LFCM, UBM, and OCT may provide much information about pathophysiologic hallmarks of Behçet’s disease. A combination of corticosteroids with other immunosuppressive agents is effective for most patients with Behçet’s disease. Males had a more severe course and were at higher risk for losing vision than females." @default.
• W2152068912 created "2016-06-24" @default.
• W2152068912 creator A5000508996 @default.
• W2152068912 creator A5005016013 @default.
• W2152068912 creator A5016194081 @default.
• W2152068912 creator A5024782400 @default.
• W2152068912 creator A5026204677 @default.
• W2152068912 creator A5089953588 @default.
• W2152068912 date "2008-02-01" @default.
• W2152068912 modified "2023-10-18" @default.
• W2152068912 title "Clinical Features of Chinese Patients with Behçet’s Disease" @default.
• W2152068912 cites W1964901687 @default.
• W2152068912 cites W1980775093 @default.
• W2152068912 cites W2009181148 @default.
• W2152068912 cites W2012943527 @default.
• W2152068912 cites W2026645142 @default.
• W2152068912 cites W2038946141 @default.
• W2152068912 cites W2049549998 @default.
• W2152068912 cites W2064729318 @default.
• W2152068912 cites W2077501466 @default.
• W2152068912 cites W2087082079 @default.
• W2152068912 cites W2100285423 @default.
• W2152068912 cites W2113168893 @default.
• W2152068912 cites W2114162691 @default.
• W2152068912 cites W2116122168 @default.
• W2152068912 cites W2116806383 @default.
• W2152068912 cites W2128430434 @default.
• W2152068912 cites W2209867202 @default.
• W2152068912 cites W2212671695 @default.
• W2152068912 cites W4239391302 @default.
• W2152068912 cites W4251362325 @default.
• W2152068912 doi "https://doi.org/10.1016/j.ophtha.2007.04.056" @default.
• W2152068912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17692378" @default.
• W2152068912 hasPublicationYear "2008" @default.
• W2152068912 type Work @default.
• W2152068912 sameAs 2152068912 @default.
• W2152068912 citedByCount "161" @default.
• W2152068912 countsByYear W21520689122012 @default.
• W2152068912 countsByYear W21520689122013 @default.
• W2152068912 countsByYear W21520689122014 @default.
• W2152068912 countsByYear W21520689122015 @default.
• W2152068912 countsByYear W21520689122016 @default.
• W2152068912 countsByYear W21520689122017 @default.
• W2152068912 countsByYear W21520689122018 @default.
• W2152068912 countsByYear W21520689122019 @default.
• W2152068912 countsByYear W21520689122020 @default.
• W2152068912 countsByYear W21520689122021 @default.
• W2152068912 countsByYear W21520689122022 @default.
• W2152068912 countsByYear W21520689122023 @default.
• W2152068912 crossrefType "journal-article" @default.
• W2152068912 hasAuthorship W2152068912A5000508996 @default.
• W2152068912 hasAuthorship W2152068912A5005016013 @default.
• W2152068912 hasAuthorship W2152068912A5016194081 @default.
• W2152068912 hasAuthorship W2152068912A5024782400 @default.
• W2152068912 hasAuthorship W2152068912A5026204677 @default.
• W2152068912 hasAuthorship W2152068912A5089953588 @default.
• W2152068912 hasConcept C118487528 @default.
• W2152068912 hasConcept C126322002 @default.
• W2152068912 hasConcept C141071460 @default.
• W2152068912 hasConcept C16005928 @default.
• W2152068912 hasConcept C167135981 @default.
• W2152068912 hasConcept C2776015282 @default.
• W2152068912 hasConcept C2776194053 @default.
• W2152068912 hasConcept C2778257484 @default.
• W2152068912 hasConcept C2778328719 @default.
• W2152068912 hasConcept C2779134260 @default.
• W2152068912 hasConcept C2780248432 @default.
• W2152068912 hasConcept C2780347916 @default.
• W2152068912 hasConcept C2781428731 @default.
• W2152068912 hasConcept C71924100 @default.
• W2152068912 hasConceptScore W2152068912C118487528 @default.
• W2152068912 hasConceptScore W2152068912C126322002 @default.
• W2152068912 hasConceptScore W2152068912C141071460 @default.
• W2152068912 hasConceptScore W2152068912C16005928 @default.
• W2152068912 hasConceptScore W2152068912C167135981 @default.
• W2152068912 hasConceptScore W2152068912C2776015282 @default.
• W2152068912 hasConceptScore W2152068912C2776194053 @default.
• W2152068912 hasConceptScore W2152068912C2778257484 @default.
• W2152068912 hasConceptScore W2152068912C2778328719 @default.
• W2152068912 hasConceptScore W2152068912C2779134260 @default.
• W2152068912 hasConceptScore W2152068912C2780248432 @default.
• W2152068912 hasConceptScore W2152068912C2780347916 @default.
• W2152068912 hasConceptScore W2152068912C2781428731 @default.
• W2152068912 hasConceptScore W2152068912C71924100 @default.
• W2152068912 hasIssue "2" @default.
• W2152068912 hasLocation W21520689121 @default.
• W2152068912 hasLocation W21520689122 @default.
• W2152068912 hasOpenAccess W2152068912 @default.
• W2152068912 hasPrimaryLocation W21520689121 @default.
• W2152068912 hasRelatedWork W1182931245 @default.
• W2152068912 hasRelatedWork W1979145563 @default.
• W2152068912 hasRelatedWork W1980202481 @default.
• W2152068912 hasRelatedWork W1983318705 @default.
• W2152068912 hasRelatedWork W2057053307 @default.
• W2152068912 hasRelatedWork W2058548650 @default.
• W2152068912 hasRelatedWork W2752661489 @default.
• W2152068912 hasRelatedWork W3045780382 @default.
• W2152068912 hasRelatedWork W3157212674 @default.

• next